Vesna Barac-Latas

Vesna Barac-Latas

Auto-generated profile, based on publicly available information

Vesna Barac-Latas

Department of Physiology and Immunology, School of Medicine, University of Rijeka, Rijeka, Croatia

Research Focus & Metrics

Academic Career Length

37Years (1990-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 January 1997 in Glia
Verified
Journal Article
Open access
PDF file
VBVesna Barac-Latas
Vesna Barac-Latas
GSGerda Suchanek
Gerda Suchanek
HBHelene Breitschopf
Helene Breitschopf
ASAlbert Stuehler
Albert Stuehler
HWHelmut Wege
Helmut Wege
HLHans Lassmann
Hans Lassmann
Intracerebral infection of rats with JHM coronavirus induces a chronic inflammatory demyelinating disease, which in many respects mimicks the pathology of multiple sclerosis. We investigated the patterns of demyelination and oligodendrocyte pathology in this model. In early stages of the disease infection of oligodendrocytes was associated with a downregulation of expression of mRNA for proteolipid protein in the absence of myelin destruction. When demyelinating lesions were formed infected oligodendrocytes were destroyed by necrosis, whereas oligodendrocytes that did not contain detectable virus antigen or RNA were in part dying by apoptosis. At this stage of the disease remyelination of the lesions was pronounced. At later stages after infection virus antigen was nearly completely cleared from the lesions. In spite of the lack of detectable virus, ongoing demyelination and unspecific tissue destruction occurred, and oligodendrocytes were mainly destroyed by apoptosis. These late lesions revealed only minimal central remyelination, but they were frequently repaired by Schwann cells. Our studies suggest that the mechanisms of myelin destruction in this model of virus-induced demyelination are complex and that the patterns of tissue damage may change during the course of the disease. Glia 19:1–7, 1997

1 January 2007 in Medical Teacher
Verified
Journal Article
Open access
LPLivia Puljak
Livia Puljak
JKJasminka Brnjas Kraljevic
Jasminka Brnjas Kraljevic
VLVesna Barac Latas
Vesna Barac Latas
DSDamir Sapunar
Damir Sapunar
Background: According to data regarding number of physicians per 100 000 inhabitants, Croatia is below the European average. Under those circumstances, more attention needs to be devoted to Croatian medical schools and their applicants. Aims: This study sought to investigate admission trends of applicants to Croatian medical schools, analyse their demographics and motives for medical school enrollment. Methods: We collected admissions data of applicants to Croatian medical schools from 1979 to 2006. Motives for and against medical school enrollment were assessed in a survey of 1146 applicants (response rate 84%, 966/1146) and 98 final-year medical students (response rate 82%, 80/98) during July 2006. Results: The number of applicants to Croatian medical schools had been declining until 1995, it was lowest during the 1991–1995 war in Croatia and it has been rising from 1996 onwards. Majority of applicants in 2006/07 were women (69%). Most of the applicants attended general high schools. The applicants profess choosing a certain medical school for its quality and reputation, but we showed that they actually chose the closest school. The main motives for medical school enrollment were humanitarian and scientific, while main reasons against were perceived difficulty and financial burden. We showed that final-year medical students profess significantly lower interest in science and that they are less interested in altruistic aspects of medicine. Instead, great number of them would reconsider choosing medical studies again because of the corruption in medicine, fear of mistakes and uncertainty of employment. Conclusions: Following the admission trends in medical schools on a national level gives insight into the prospects of health care. Analysis of motives for and against medical school enrollment can provide guidelines for their improvement. Unless Croatia and other countries in transition devote more attention to recruitment, education and retention of physicians, the prospects of our healthcare are poor.

1 August 2012 in Croatian Medical Journal
Verified
Journal Article
Open access
KBKarolina Balajić
Karolina Balajić
VBVesna Barac-Latas
Vesna Barac-Latas
IDInes Drenjancevic
Ines Drenjancevic
MOMarko Ostojić
Marko Ostojić
DFDamir Fabijanić
Damir Fabijanić
LPLivia Puljak
Livia Puljak
To investigate whether the introduction of a vertical subject on research in biomedicine and founding of The Cochrane Collaboration branch at the University of Split School of Medicine influenced students’ knowledge and attitudes toward evidence-based ...

30 June 2013 in Current Aging Science
Verified
Journal Article
Closed access
PDF file
HJHrvoje Jakovac
Hrvoje Jakovac
MTMarin Tota
Marin Tota
DGDamir Grebić
Damir Grebić
TGTanja Grubic-Kezele
Tanja Grubic-Kezele
VBVesna Barac-Latas
Vesna Barac-Latas
BRBiserka Radošević-Stašić
Biserka Radošević-Stašić
Metallothioneins (MTs) are small, cysteine-rich proteins which have been implicated in various forms of stress providing cytoprotective action against oxidative injury, DNA damage and apoptosis. Owing to their high affinity for physiological metals, such as zinc and copper MTs are also critical components of regulatory proteins involved in cell growth and multiplication, as well as in the maintenance of immune homeostasis. To elucidate the role of MTs in the pathomechanisms of autoimmune CNS disorders we estimated the expression of MT I+II proteins and the content of free Zn ions in the brain, spinal cord and in the liver early in the course of chronic relapsing experimental autoimmune encephalomyelitis (CR-EAE) pathogenesis, i.e. before the onset of any clinical symptoms. Disease was induced in the genetically susceptible Dark Agouti (DA) rats by subcutaneous injection of bovine brain homogenate in CFA. Control animals were treated with CFA alone. The data, obtained by immuno-histochemistry and in situ fluorescent labeling of free zinc ions, have shown that in the presymptomatic phase of CR-EAE (on the seventh postimmunization day) MTs I+II were markedly upregulated in the cells that form blood-brain and blood-cerebrospinal fluid barriers, as well as in the cerebellar parenchyma and hippocampal dentate gyri. Furthermore, we found that the liver also becomes a site of extensive MTs I+II synthesis shortly after immunization. Simultaneously, tissue content of free zinc ions increased at the sites of MTs induction, reflecting their antioxidative activity. The data, described in this paper point to regulatory and neuroprotective role of MTs in the pathogenesis of CR-EAE.

1 December 2016 in NeuroToxicology
Verified
Journal Article
Closed access
BĆBožena Ćurko-Cofek
Božena Ćurko-Cofek
Tanja Grubić KezeleTanja Grubić Kezele
Tanja Grubić Kezele
JMJelena Marinic
Jelena Marinic
MTMarin Tota
Marin Tota
NČNada Starčević Čizmarević
Nada Starčević Čizmarević
VBVesna Barac-Latas
Vesna Barac-Latas

1 June 2006 in Multiple Sclerosis Journal
Verified
Journal Article
Closed access
SRSmiljana Ristić
Smiljana Ristić
LLLuca Lovrečić
Luca Lovrečić
NCNada Starcevic Cizmarevic
Nada Starcevic Cizmarevic
BBBojana Brajenović-Milić
Bojana Brajenović-Milić
SJSaša Šega Jazbec
Saša Šega Jazbec
BPBorut Peterlin
Borut Peterlin
Several studies investigating the role of the CCR5D32 mutation in multiple sclerosis (MS) have reported varied, often contradictory results. Therefore in the present study we have analysed whether the CCR5D32 mutation is associated with the risk of/or disease process in Croatian and Slovene MS patients. Three hundred and twenty-five MS patients and 356 healthy controls were genotyped by the polymerase chain reaction method. Our results showed no significant differences in the distribution of CCR5D32 mutations between MS and control subjects, indicating that this mutation does not influence susceptibility to MS. Furthermore, we did not observe that CCR5D32 carrier-status could modulate age of disease onset or progression of the disease. It is therefore our conclusion that the present study indicates that the CCR5D32 mutation is neither protective of, nor a risk factor, for MS development.